Sirexatamab

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

February, 2025

Sirexatamab

Jan 31, 2025, 19:25 | Insight

Tanja Obradovic: New Phase III trial with an innovative MOA may soon change the standard of care for second-line MSS CRC

Tanja Obradovic, Oncology Medical Strategy Advisor at Mercurial AI, shared a post on LinkedIn: "New…

All: 1 Posts: 1 - 100

'

FDA Approves T-DXd for HR+, HER2-Low/Ultralow Breast Cancer Treatment

'

Oncologist Near Me - Hagop Kantarjian: A Legend in Leukemia Research and Treatment

'

New Paper Alert: Botensilimab and Balstilimab in Relapsed/Refractory Metastatic Sarcomas

'

Best of ASCOGI25

'

Egypt Cancer Society (ECS) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023